We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

181 hedge funds and large institutions have $1.47B invested in Cytokinetics in 2020 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 86 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 36

115% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 20

24% more call options, than puts

Call options by funds: $62.7M | Put options by funds: $50.4M

15% more funds holding

Funds holding: 158 → 181 (+23)

8% more capital invested

Capital invested by funds: $1.36B → $1.47B (+$108M)

0.24% more ownership

Funds ownership: 97.37% → 97.6% (+0.24%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
181
Holders Change
+23
Holders Change %
+14.56%
% of All Funds
3.65%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
43
Increased
86
Reduced
36
Closed
20
Calls
$62.7M
Puts
$50.4M
Net Calls
+$12.3M
Net Calls Change
+$14.9M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$77.7M
2
RI
RTW Investments
New York
+$46.8M
3
BlackRock
BlackRock
New York
+$32.7M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$29.9M
5
GPP
Great Point Partners
Connecticut
+$24.1M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$78.9M
2
Millennium Management
Millennium Management
New York
-$12.7M
3
PC
Polar Capital
United Kingdom
-$11.8M
4
Jennison Associates
Jennison Associates
New York
-$8.11M
5
Invesco
Invesco
Georgia
-$3.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
176
Advisory Services Network
Georgia
$3K +$3.51K +150 New
ST
177
Smithfield Trust
Pennsylvania
$3K +$3.63K +155 New
MAM
178
Meeder Asset Management
Ohio
$2K – – –
PFBT
179
Parkside Financial Bank & Trust
Missouri
$2K – – –
QCG
180
Quadrant Capital Group
Ohio
$1K +$140 +6 +11%
CCM
181
Consonance Capital Management
New York
– -$78.9M -3,347,232 Closed
PC
182
Polar Capital
United Kingdom
– -$11.8M -500,000 Closed
EP
183
Eversept Partners
New York
– -$3.34M -141,700 Closed
Renaissance Technologies
184
Renaissance Technologies
New York
– -$1.68M -71,067 Closed
CM
185
Caption Management
Oklahoma
– -$1.44M -61,600 Closed
Hudson Bay Capital Management
186
Hudson Bay Capital Management
Connecticut
– -$1.18M -50,000 Closed
D.E. Shaw & Co
187
D.E. Shaw & Co
New York
– -$1.16M -49,028 Closed
AIM
188
Aigen Investment Management
New York
– -$1.09M -46,412 Closed
AC
189
Athanor Capital
New York
– -$983K -41,696 Closed
SEI Investments
190
SEI Investments
Pennsylvania
– -$503K -21,326 Closed
WCM
191
Weld Capital Management
New York
– -$325K -13,774 Closed
MFG
192
Magnus Financial Group
New York
– -$284K -12,067 Closed
TCM
193
Teza Capital Management
Illinois
– -$244K -10,372 Closed
SPC
194
Sigma Planning Corp
Michigan
– -$229K -9,700 Closed
FMT
195
First Mercantile Trust
Tennessee
– -$104K -4,396 Closed
LIA
196
LS Investment Advisors
Michigan
– -$51K -2,152 Closed
DWA
197
Dorsey Wright & Associates
California
– -$17K -712 Closed
EWM
198
Edge Wealth Management
New York
– -$12K -500 Closed
PAG
199
Private Advisor Group
New Jersey
– -$7K -291 Closed
OPS
200
Orion Portfolio Solutions
Nebraska
– -$2K -67 Closed
5 6 7
8
9

CYTK Hedge Fund Activity: Q3 2020 in Review

181 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2020, worth a combined $1.47B — up 7.9% from $1.36B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new CYTK positions and 20 closed out — a net gain of 23 holders — while 86 added to existing stakes and 36 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $77.7M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $78.9M sold.

  • 181 institutional investors held Cytokinetics (CYTK) as of Q3 2020, up from 158 in Q2 2020.
  • Funds reported $1.47B of Cytokinetics stock for Q3 2020, up 7.9% quarter-over-quarter.
  • 43 funds opened new Cytokinetics positions in Q3 2020 and 20 closed out, a net change of +23 holders.
  • The largest Cytokinetics buyer in Q3 2020 was BVF Inc, an estimated $77.7M added.
  • The largest Cytokinetics seller in Q3 2020 was Consonance Capital Management, an estimated $78.9M sold.

Based on aggregated 13F filings for Q3 2020.